A novel in vitro model for evaluating drug-induced QT prolongation using genetically modified human iPS-derived cardiomyocytes

被引：0

作者：

Li, Min ^{[1
]}

Kanda, Yasunari ^{[2
]}

Ashihara, Takashi ^{[3
]}

Sasano, Tetsuo ^{[1
]}

Sekino, Yuko ^{[2
]}

Furukawa, Tetsushi ^{[1
]}

Kurokawa, Junko ^{[1
]}

机构：

[1] TMDU, MRI, Dept Biobioinfo Phamacol, Bunkyo Ku, Tokyo 1138510, Japan

[2] NIHS, Div Pharmacol, Setagaya Ku, Tokyo 1588501, Japan

[3] Shiga Univ Med Sci, Dept Cardiovasuc Resp Med, Otsu, Shiga 5202192, Japan

来源：

JOURNAL OF PHARMACOLOGICAL SCIENCES | 2014年 / 124卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：86P / 86P

页数：1

共 50 条

[1] Assessment of drug-induced QT prolongation using human iPS cell-derived mature cardiomyocytes
Kanda, Yasunari
Li, Min
Ashihara, Takashi
Sekino, Yuko
Furukawa, Tetsushi
Kurokawa, Junko
[J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2016, 81 : 384 - 384
[2] A Novel Approach for Evaluation of Drug-Induced QT Prolongation using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Li, Min
Kanda, Yasunari
Sekino, Yuko
Furukawa, Tetsushi
Kurokawa, Junko
[J]. BIOPHYSICAL JOURNAL, 2014, 106 (02) : 720A - 721A
[3] An iPS-derived in vitro model of human atrial conduction
Biendarra-Tiegs, Sherri M.
Yechikov, Sergey
Shergill, Bhupinder
Brumback, Brittany
Takahashi, Kentaro
Shirure, Venktesh S.
Gonzalez, Ruth Estelle
Houshmand, Laura
Zhong, Denise
Weng, Kuo-Chan
Silva, Jon
Smith, Timothy W.
Rentschler, Stacey L.
George, Steven C.
[J]. PHYSIOLOGICAL REPORTS, 2022, 10 (18):
[4] Modeling of cardiac ischaemia and reperfusion injury: a human-based in vitro model using iPS-derived cardiomyocytes
Pinho, J.
Scrimgeour, N. R.
Stolen, T.
Solvang-Garten, K.
Sharma, A.
Fonseca, D. Miranda
Smith, G.
Hoydal, M.
[J]. EUROPEAN HEART JOURNAL, 2017, 38 : 229 - 230
[5] Drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes
Yamazaki, Daiju
Kitaguchi, Takashi
Ishimura, Masakazu
Taniguchi, Tomohiko
Yamanishi, Atsuhiro
Saji, Daisuke
Takahashi, Etsushi
Oguchi, Masao
Moriyama, Yuta
Maeda, Sanae
Miyamoto, Kaori
Morimura, Kaoru
Ohnaka, Hiroki
Tashibu, Hiroyuki
Sekino, Yuko
Miyamoto, Norimasa
Kanda, Yasunari
[J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 170 - 170
[6] QUANTIFICATION OF CONTRACTILE PROPERTY FOR FUNCTIONAL DRUG TESTING WITH HUMAN IPS-DERIVED CARDIOMYOCYTES
Morimoto, Yuya
Mori, Saori
Sakai, Fusako
Takeuchi, Shoji
[J]. 2016 IEEE 29TH INTERNATIONAL CONFERENCE ON MICRO ELECTRO MECHANICAL SYSTEMS (MEMS), 2016, : 271 - 274
[7] Establishment of a method for evaluating the drug-induced QT prolongation with human induced pluripotent stem cell-derived cardiomyocytes-with a focus on the evaluation of multichannel blockers
Nozaki, Yumiko
Honda, Yayoi
Tsujimoto, Shinji
Kunimatsu, Takeshi
Funabashi, Hitoshi
[J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2014, 70 (03) : 318 - 318
[8] Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes
Shinozawa, Tadahiro
Nakamura, Koki
Shoji, Masanobu
Morita, Maya
Kimura, Maya
Furukawa, Hatsue
Ueda, Hiroki
Shiramoto, Masanari
Matsuguma, Kyoko
Kaji, Yoshikazu
Ikushima, Ippei
Yono, Makoto
Liou, Shyh-Yuh
Nagai, Hirofumi
Nakanishi, Atsushi
Yamamoto, Keiji
Izumo, Seigo
[J]. STEM CELL REPORTS, 2017, 8 (02): : 226 - 234
[9] In vitro pharmacology and safety testing using human iPS-derived Cor.4U cardiomyocytes
Kettenhofen, Ralf
Tressat, Kristina
Kolossov, Eugen
Hebeisen, Simon
Jaehne, Evelyn
Ehlich, Andreas
Schwengberg, Silke
Bohlen, Heribert
[J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2013, 68 (01) : E7 - E7
[10] Identification of CV liabilities in the xCELLigence system using human iPS-derived cardiomyocytes
Kazusa, Katsuyuki
Watanabe, Yudai
Nagata, Keisuke
Sato, Yumiko
Fujimori, Chikara
Shirakawa, Takafumi
Okada, Akinobu
[J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2016, 81 : 344 - 344

← 1 2 3 4 5 →